Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.
Good interview overall. I'm almost certain they don't have the money to get PoC up and running judging by the interims, so I was disappointed to hear no mention of funding that in the interview. Hopefully can be funded through debt rather than equity though owing to the ease of profitability mentioned in the interview.
Get it profitable, get it sold - move onto the next one. It's worked for this team before, it'll work again. Happy to hold and buy more at these levels.
Hi del - just a quick one, I don’t think the Rosgeo JV was the reason we left the FSP, it was because the board had received (wording not verbatim but roughly correct); “an offer from a credible party to purchase substantially all of our assets.”
The JV with Rosgeo came after. For this reason I’m hopeful that MT is up for sale on its own, and that this will become actionable after the MT DFS is complete. Perhaps the buyer might get a right of first refusal to purchase Nyud from us once developed too - that’s pure speculation on my part but what I’m hoping for from all we know so far…
Interesting to consider what’s made the market cap of the company more than halve since then. In my view the riskiest days of the war to the company were end of Feb - late June when nobody knew what was going to happen and sanctions were being applied. Now everyone knows where the company stands, that it’s unaffected, and yet the value has apparently sunk. Doesn’t make sense to me, which is why I’ve been buying more throughout.
Those sells this morning were fairly large for average daily volume but vol bought / sold isn’t far off equal if you believe the numbers, so shouldn’t have had too much of an impact. I can’t understand why people are selling right now either - it’s not a share for traders, it’s a long term hold so unless somebody’s had a cash call I’m stumped
No idea what’s going on. A sea of buys (and I believe they are actually buys as well based on the price I can currently sell at) and the share price drifting down. Shame I’ve no spare cash at the moment to buy more… Already been told that this months interims are going to be decent m
Just to do with how the LSE records trades - it's based on the official mid price at the time. If you've bought shares below the mid price, it will be flagged as a sell. Similarly if you've sold them above the mid price, it would be flagged as a buy. Nothing to worry about - it happens with every share.
Well, I also bought in coming out of the covid recovery when the share price had slipped from 20p to roughly 11.5. Partly hoping for a short term post-covid bounce and also because I like the company fundamentals, and (less important but a factor) the exposure to the share price for Anthony Burt. While it’s been painful to see the share price drop to such lows I haven’t considered selling - in fact I’ve managed to lower my average to 3.5p so at present I’m pretty happy.
Agree that finally seeing the share price bounce off its rocky bottom is pleasing, but I’m personally less interested in whatever relatively insignificant loss the company might make in 2022, and far more interested in the 5-10 year potential of a quality brand expanding globally and carving out a significant piece of the high end part of the beverage market for itself.
Depends what you’re looking for really, a long term investment or a profitable trade. Good luck either way with whatever you decide!
Only real downside at the moment is strong competition from the budget sector. I still, sadly, haven’t been able to sample EISB’s range yet as they don’t currently retail where I’m based, but have been back in the UK this month for the first time in a year and there’s a number of new brands at the lower end of the market which I’ve been trying and are actually really decent. East Imperial however are far ahead in terms of targeted marketing when it comes to the markets that they operate in so I’m optimistic this won’t be a problem.
Huge expansion currently taking place across the US in terms of bottling and distribution; UK bottling and distribution in the pipeline for 2023; Asian and Australasian sales levels up to where they were pre-Covid when the market cap was significantly higher than it is now; and the Co has stockpiled raw materials already accounted for in the 2021 accounts to protect against shortages and price increases.
For me, hard to see a downside. There may well be some more share dilution coming down the line to fund more expansion but I’m confident this can be delayed until the share price is back up higher than where we are now.
Personally as and when cash flow allows I’m looking to get hold of more shares here before the rest of the market catches up…
Topped up this afternoon - £3k buy is mine. Lowering my average to just shy of 4p, with the expectation that the interim report due in September will show a substantial boost to the company's fundamentals as a result of the US distribution agreement.